Shopping Cart
  • Remove All
  • TargetMol
    Your shopping cart is currently empty
Filter
Applied FilterClear all
TargetMol | Tags By Target
  • Apoptosis
    (1)
  • CSF-1R
    (1)
  • FLT
    (1)
  • PDGFR
    (1)
  • Src
    (1)
  • c-Kit
    (1)
Filter
Search Result
Results for "

387867-13-2

" in TargetMol Product Catalog
  • Inhibitors & Agonists
    3
    TargetMol | Activity
Tandutinib
T1667387867-13-2
Tandutinib (CT53518) (MLN518, CT53518), an effective FLT3 antagonist (IC50: 0.22 μM), can also inhibit c-Kit and PDGFR, 15-20 fold higher potency for FLT3 versus CSF-1R and >100-fold selectivity for the same target versus FGFR, EGFR, and KDR.
  • Inquiry Price
Size
QTY
TargetMol | Inhibitor Sale
Tandutinib (MLN518) HCl
T23418
Tandutinib is an effective antagonist for FLT3, platelet-derived growth factor receptor (PDGFR), and c-Kit. Tandutinib potently inhibited the activity of FLT3, PDGFR, and c-Kit (IC50: ~200 nM).
  • Inquiry Price
Size
QTY
Tandutinib hydrochloride
T642262438900-70-8
Tandutinib hydrochloride (MLN518 hydrochloride) is a potent, selective FLT3 inhibitor with an IC50 of 0.22 μM and also effectively inhibits c-Kit and PDGFR, with IC50 values of 0.17 μM and 0.20 μM, respectively. This compound is clinically applicable for treating acute myelogenous leukemia (AML) and can cross the blood-brain barrier.
  • Inquiry Price
1-2 weeks
Size
QTY